The U.S. Centers for Disease Control and Prevention (CDC) released its final update on the Salmonella Braenderup infections linked to nut butters manufactured by nSpired Natural Foods. Six people were infected with the strain of Salmonella Braenderup since Jan. 1, 2014, in Connecticut, Iowa, New Mexico, Tennessee and Texas. Illness onset dates ranged from Jan. 20, 2014, to May 16, 2014. Ill persons ranged in age from two years to 83 years, with a median age of 35 years. Sixty-six percent of ill persons were female. Among five ill persons with available information, one was hospitalized. No deaths were reported. During routine inspections at an nSpired Natural Foods facility in Ashland, OR, in February and July 2014, FDA isolated Salmonella Braenderup from environmental samples. PFGE and whole-genome sequencing were performed on the environmental isolates by FDA to further characterize the bacteria. A subsequent search of the PulseNet database identified ill persons with the same PFGE “fingerprint” of Salmonella Braenderup. Whole-genome sequencing was performed on these clinical isolates, and the bacteria from six of the ill persons were found to be related to the environmental isolates taken from the firm. Five of the six ill persons were interviewed and answered questions about foods eaten and other exposures during the week before becoming ill. Four of them reported eating peanut or almond butter, and all four reported eating a brand of peanut or almond butter produced by nSpired Natural Foods Inc. On Aug. 19, 2014, nSpired Natural Foods Inc. voluntarily recalled certain lots of almond and peanut butters because of potential contamination with Salmonella. The recalled brands included Arrowhead Mills, MaraNatha, Trader Joe’s, Whole Foods, Safeway and Kroger. This outbreak investigation is now over, but the recalled nut butter products have a long shelf life and may still be in people’s homes. Consumers unaware of the recall could continue to eat the products and potentially get sick. CDC’s National Antimicrobial Resistance Monitoring System (NARMS) laboratory conducted antibiotic-resistance testing on the Salmonella Braenderup isolates collected from four ill persons infected with the outbreak strain, and all were found to be susceptible to all antibiotics tested on the NARMS panel.